Immix Biopharma, Inc. Common Stock (IMMX)
PHARMACEUTICAL PREPARATIONS
Immix Biopharma, Inc. Common Stock (IMMX) is listed on Nasdaq, where it has traded since December 16, 2021.
- Listed On
- Nasdaq
- Listed Since
- December 16, 2021
- Employees
- 21
- Market Cap
- $785M
About Immix Biopharma, Inc. Common Stock
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 105 institutions reported holding IMMX, with 56.2 million shares worth $579.4 million in aggregate. The largest reported holder was Jupiter Topco, with 9.8 million shares worth $100.8 million. Of the 5 largest holders listed below, 1 opened a new position in IMMX and 4 added shares during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Jupiter Topco | 9,783,192 | $101M | New position |
| Saturn V Capital Management | 4,658,429 | $48M | Added 26.12% |
| Eventide Asset Management | 3,891,019 | $40M | Added 52.65% |
| Vanguard | 3,218,960 | $33M | Added 56.21% |
| State Street | 2,996,935 | $31M | Added 1461.64% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is IMMX?
Immix Biopharma, Inc. Common Stock (IMMX) is listed on Nasdaq, where it has traded since December 16, 2021.
Who are the largest institutional holders of IMMX?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of IMMX were Jupiter Topco, Saturn V Capital Management and Eventide Asset Management.
How many institutions own IMMX?
105 institutions reported a position in IMMX for the quarter ended June 30, 2026, worth $579.4 million in total.
Did institutions buy or sell IMMX last quarter?
Of the 5 largest reported holders, 1 opened a new position in IMMX and 4 added shares during the quarter. Every reported holder and its change is on the SentiSense ownership page for IMMX.
Every reported institutional holder, plus insider and congressional trades in IMMX, on SentiSense.